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Sir,
As observed by Dr Zahl, it is correct that the cumulative risk in
breast cancer incidence increased during the observed period.
Indeed, breast cancer incidence has increased steadily in Denmark
since the 1960s (Sundhedsstyrelsen, 2003). Assuming linearity in
the cumulative risk, we performed a simple least-squares
estimation of the trend in breast cancer incidence in the period
before screening for both Copenhagen and Fyn. Assuming this
trend would have continued if screening had not been introduced,
the expected cumulative risk for Copenhagen in 1993–95 was
6.6% and the observed cumulative risk was 6.1% (95% CI
5.3–6.8%). For Fyn the expected cumulative risk for 1996–97
was 5.9%, whereas the observed cumulative risk was 6.6% (95%
CI 5.9–7.3%). For both Fyn and Copenhagen the expected
cumulative risk was within the 95% confidence interval.
Therefore, we see no reason to conclude that overdiagnosis is
taking place.
If the underlying increase in the incidence before screening was
partly due to opportunistic screening, this would not affect the
conclusions since the increase in the number of clinical
mammography examinations continued after the introduction of
screening (Olsen et al, 2003).
It is correct that bringing the time of diagnosis forward should
result in a lower incidence in the age group 70–74, and we plan to
look at this effect for Copenhagen and Fyn. But whereas entry into
the screening programmes is well defined, exit is not. In the second
invitation round in Copenhagen, women in the age group 70–71
were invited. In Fyn, women over 70 can participate if they ask for
it. This will dilute the effect, and therefore we have not yet
performed this analysis.
As mentioned in the article (Olsen et al, 2003), inclusion of
screen-detected DCIS did not change the picture. Note that the
proportion of DCIS detected in the Danish screening programmes
is small compared to that in many other programmes, due to a
deliberately conservative attitude towards supposedly benign
microcalcifications (Vejborg et al, 2002).
We will follow the further development of breast cancer
incidence in Denmark.
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